Tieton Capital Management’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-118,456
Closed -$3.27M 33
2021
Q4
$3.27M Sell
118,456
-10,955
-8% -$302K 1.83% 26
2021
Q3
$4.18M Sell
129,411
-3,760
-3% -$121K 2.27% 21
2021
Q2
$4.07M Sell
133,171
-49,950
-27% -$1.53M 2.17% 22
2021
Q1
$5.58M Sell
183,121
-4,515
-2% -$137K 3.21% 17
2020
Q4
$3.71M Sell
187,636
-6,334
-3% -$125K 2.72% 21
2020
Q3
$2.53M Buy
193,970
+27,529
+17% +$359K 2.5% 22
2020
Q2
$1.89M Buy
166,441
+1,790
+1% +$20.3K 2.36% 21
2020
Q1
$2.36M Sell
164,651
-16,389
-9% -$235K 3.79% 16
2019
Q4
$4.93M Buy
181,040
+9,206
+5% +$251K 3.94% 10
2019
Q3
$4.92M Buy
171,834
+11,400
+7% +$326K 4.19% 10
2019
Q2
$4.46M Buy
160,434
+62,235
+63% +$1.73M 3.9% 12
2019
Q1
$3.26M Buy
98,199
+86,229
+720% +$2.86M 2.9% 21
2018
Q4
$348K Sell
11,970
-79,978
-87% -$2.33M 0.39% 30
2018
Q3
$4.23M Sell
91,948
-30,450
-25% -$1.4M 3.37% 16
2018
Q2
$4.57M Sell
122,398
-30
-0% -$1.12K 3.54% 14
2018
Q1
$3.62M Sell
122,428
-1,910
-2% -$56.4K 3.32% 18
2017
Q4
$4.27M Sell
124,338
-126,805
-50% -$4.35M 3.67% 15
2017
Q3
$9.09M Sell
251,143
-15,350
-6% -$555K 7.81% 2
2017
Q2
$6.89M Sell
266,493
-30,675
-10% -$793K 6.36% 3
2017
Q1
$5.71M Buy
297,168
+104,073
+54% +$2M 4.95% 6
2016
Q4
$3.22M Sell
193,095
-920
-0.5% -$15.3K 2.51% 21
2016
Q3
$3.99M Buy
194,015
+92,225
+91% +$1.9M 3.43% 17
2016
Q2
$3.12M Sell
101,790
-5,667
-5% -$173K 3.03% 16
2016
Q1
$4.02M Sell
107,457
-11,833
-10% -$443K 3.85% 14
2015
Q4
$5.15M Sell
119,290
-22,120
-16% -$955K 4.04% 12
2015
Q3
$5.3M Sell
141,410
-2,249
-2% -$84.3K 4.95% 7
2015
Q2
$4.88M Sell
143,659
-2,991
-2% -$102K 3.81% 11
2015
Q1
$5.19M Buy
146,650
+2,740
+2% +$97K 3.9% 13
2014
Q4
$4.9M Sell
143,910
-118,875
-45% -$4.05M 4.04% 14
2014
Q3
$10.1M Buy
+262,785
New +$10.1M 7.43% 1